Sionna Therapeutics (SION) Leases (2024 - 2026)
Quarterly results put Leases at $6.7 million for Q1 2026, down 12.3% from a year ago — trailing twelve months through Mar 2026 was $6.7 million (down 12.3% YoY), and the annual figure for FY2025 was $6.9 million, down 11.57%.
Sionna Therapeutics has reported Leases over the past 3 years, most recently at $6.7 million for Q1 2026.
- Leases reached $6.7 million in Q1 2026 per SION's latest filing, down from $6.9 million in the prior quarter.
- Across five years, Leases topped out at $7.8 million in Q4 2024 and bottomed at $6.7 million in Q1 2026.
- Median Leases over the past 3 years was $7.3 million (2025), compared with a mean of $7.3 million.
- The largest annual shift saw Leases dropped 11.57% in 2025 before it fell 12.3% in 2026.
- Over 3 years, Leases stood at $7.8 million in 2024, then fell by 11.57% to $6.9 million in 2025, then decreased by 3.55% to $6.7 million in 2026.
- Business Quant data shows Leases for SION at $6.7 million in Q1 2026, $6.9 million in Q4 2025, and $7.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 83,048.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 61,822.50 |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 285.20 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.69 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 189.30 Mn |
| 10 | Sionna Therapeutics | 1.87 Bn | 1.87 Bn | - | 6.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.68 Mn |
| Dec 31, 2025 | 6.93 Mn |
| Sep 30, 2025 | 7.17 Mn |
| Jun 30, 2025 | 7.40 Mn |
| Mar 31, 2025 | 7.62 Mn |
| Dec 31, 2024 | 7.83 Mn |